WHO ICTRP trial
Clinical trial of CIM-Meg19 to combat the severity of disorders in COVID-19 and…
CTRI/2021/05/033472 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2021/05/033472 |
|---|---|
| Public title | Clinical trial of CIM-Meg19 to combat the severity of disorders in COVID-19 and post COVID-19 patients |
| Scientific title | A study to assess efficacy and safety of proprietary Ayurvedic formulation [CIM-MEG19] as immune booster as well as alternate standard care in COVID-19 positive and post- COVID-19 patients to combat the severity/recovery of symptoms/disorders - CSIR-CIMAP [CIM-Meg19] |
| Primary sponsor | Ms Meghdoot Gramodyog Sewa Sansthan |
| Secondary sponsors | Council of Scientific and Industrial Research CSIR |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | India |
| Conditions | Health Condition 1: - Health Condition 2: B972- Coronavirus as the cause of diseases classified elsewhere |
| Interventions | Intervention1: CIM-Meg19: Dosage Form: 02 Tablets Duration : Day 1 to Day 21 Route: Orally twice daily after meal. Control Intervention1: Standard of care: 1. Patients on Standard care medicines who are not willing to take the drug… |
| Registration date | Jul 5, 2021 |
| Target size | 80 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: